- New Androgen Receptor Axis-Targeted Agents inthe Treatment of Nonmetastatic Castration-ResistantProstate Cancer: From Bench to Clinical Trials
-
Hong JH
- KMID: 2505888
- Korean J Urol Oncol.
- 2020 Aug;18(2):.
- doi: 10.22465/kjuo.2020.18.2.99
Bone metastasis is a common sign of disease progression in nonmetastatic castration-resistant prostate cancer(nmCRPC). It has been known to be associated with significant morbidity and mortality. Delaying or preventingdevelopment of... -
- CITED
-
- Close
- SHARE
-
- Close
- Epigenetic Approaches to the Treatment of Renal Cell Cancer
-
Hong SH, Lee J, Jang EB, Park SY, Moon HS, Yoon YE
- KMID: 2505886
- Korean J Urol Oncol.
- 2020 Aug;18(2):78-90.
- doi: 10.22465/kjuo.2020.18.2.78
To summarize the epigenetics in renal cell carcinoma (RCC) and discuss the potential use of epigenetic modifiersas RCC biomarkers and treatments. Pertinent articles available on PubMed and google scholar database... -
- CITED
-
- Close
- SHARE
-
- Close
- Approaches for Personalized Drug Development in Bladder Cancer Patients
-
Seol HS, Chang IH
- KMID: 2505887
- Korean J Urol Oncol.
- 2020 Aug;18(2):91-98.
- doi: 10.22465/kjuo.2020.18.2.91
Bladder cancer, which affects the bladder mucosa, is the ninth most common disease worldwide. There are manytypes of cancerous tissue in the bladder. Most exhibit low malignancy, but their recurrence... -
- CITED
-
- Close
- SHARE
-
- Close
- Open Partial Nephrectomy With Zero IschemiaTechnique Using Thulium Laser: Our Experience of4 Cases
-
Prem K, Kumar P, Rehman ZU, Janoria S
- KMID: 2505945
- Korean J Urol Oncol.
- 2020 Aug;18(2):155-160.
- doi: 10.22465/kjuo.2020.18.2.155
With the advent of newer technologies, the management of small renal masses has shown a paradigm shift.This has resulted in preferring partial nephrectomy over radical nephrectomy, emphasizing the concept of... -
- CITED
-
- Close
- SHARE
-
- Close
- Estramustine Phosphate Monotherapy in Castration-Resistant Prostate Cancer Patients Who Cannot Receive Cytotoxic Chemotherapy
-
Ryu JH, Kim SJ, Kim YB, Jung TY, Moon KT, Cho JM, Yoo TK
- KMID: 2505942
- Korean J Urol Oncol.
- 2020 Aug;18(2):140-146.
- doi: 10.22465/kjuo.2020.18.2.140
Purpose: To investigate whether estramustine phosphate (EMP) monotherapy is applicable to castration-resistantprostate cancer (CRPC) patients who cannot receive cytotoxic chemotherapy. Materials and Methods: This retrospective single-arm study was conducted in CRPC... -
- CITED
-
- Close
- SHARE
-
- Close
- Potential Utility of Prostate Health Index Density for Prostate Cancer Detection and Prediction in Korean Men: A Prospective Multicenter Study
-
Song G, Park H, Lee SW, Kang TW, Jung JH, Chung HC, Kim SJ, Park JY, Kim JH
- KMID: 2505944
- Korean J Urol Oncol.
- 2020 Aug;18(2):147-154.
- doi: 10.22465/kjuo.2020.18.2.147
Purpose: We evaluated the clinical performance of Prostate Health Index (PHI) density with [-2]proPSA (p2PSA)and its derivatives in predicting the presence of prostate cancer (PCa) in Korean men. Materials and Methods:... -
- CITED
-
- Close
- SHARE
-
- Close
- Serum Testosterone Level Can Be Predictive Factor for Upstaging in Clinically Localized Prostate Cancer
-
Kwon SO, Byeon KH, Chung JW, Ha YS, Choi SH, Kim BS, Kim HT, Kim TH, Yoo ES, Yoon GS, Lee JN, Kwon TG
- KMID: 2505892
- Korean J Urol Oncol.
- 2020 Aug;18(2):116-123.
- doi: 10.22465/kjuo.2020.18.2.116
Purpose: To determine an appropriate surgical technique, it is important to predict pathological results for patientswith clinically localized prostate cancer (PCa) eligible for nerve-sparing radical prostatectomy (NSRP). Severalstudies have highlighted... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk Factors for pT3a Prostate Cancerin the Patients With cT1-2 on PreoperativeMultiparametric Magnetic Resonance Imaging
-
Kim KH, Ku JY, Park WY, Hong SB, Kim S, Ha HK
- KMID: 2505890
- Korean J Urol Oncol.
- 2020 Aug;18(2):109-115.
- doi: 10.22465/kjuo.2020.18.2.109
Purpose: Our study aimed to evaluate the predictive value of multiparametric magnetic resonance imaging (mpMRI)to assess the capsular extension of prostate cancer. Risk factors for extraprostatic invasion or microscopic invasionof... -
- CITED
-
- Close
- SHARE
-
- Close
- Therapeutic Options in High-Risk Nonmuscle Invasive Bladder Cancer During the Shortage of Bacillus Calmette-Guérin
-
Yoo J, Kim YJ, Tae BS, Park JY
- KMID: 2505884
- Korean J Urol Oncol.
- 2020 Aug;18(2):73-77.
- doi: 10.22465/kjuo.2020.18.2.73
Bladder cancer is the second most common malignant tumor of the urinary tract and is the seventh most commoncancer among men worldwide and 17th among women. Seventy to eighty percent... -
- CITED
-
- Close
- SHARE
-
- Close
- Management of Patients With Advanced Prostate Cancer: Establishment ofTreatment Guidelines Through Prostate Cancer Summit (PCAS) 2016Composed of Korean Prostate Cancer Experts
-
Jang CT, Kim HJ, Kim MK, Park SW, Park SC, Park JY, Lee DH, Lee SH, Jeon HG, Chung JH, Jeong H, Jo MK, Hong SH, Kwak C, Lee JY, Kwon DD, Kim CS, Jeon SS
- KMID: 2505893
- Korean J Urol Oncol.
- 2020 Aug;18(2):124-139.
- doi: 10.22465/kjuo.2020.18.2.124
Purpose: The Advanced Prostate Cancer Consensus Conference (APCCC) 2015 was based on topics withcontroversy in the field of advanced prostate cancer. To understand the Korean urologists perspective regardingthe issues, we... -
- CITED
-
- Close
- SHARE
-
- Close
